Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus

标题: Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
title: Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
版本: 原创版
version: Original
分类: 标准指南
classification: Standard guideline
领域: 诊疗
field: Diagnosis and Treatment
国家和地区: 中国
Country and region: China
指南使用者: (全国各个国家和地区)为红斑狼疮患者提供临床诊疗服务的皮肤科医师和风湿科医师。
Guide users: Dermatologists and rheumatologists all over the world, who provide clinical care for patients with lupus erythematosus.
证据分级方法: Due to the limited clinical evidence available for most of therapeutic measures applied for CLE, all participants in the guideline committee agreed to develop this guideline based on both expert consensus and evidence. Voting results for each recommendation were calculated. Recommendations passing a 90% agreement or above in votes were regarded as strong consensus, and recommendations with a 70-89% agreement in votes were regarded as consensus. All recommendations in this guideline passed with a >80% agreement.
Evidence grading method:
制定单位: 亚洲皮肤科学会,亚洲皮肤病学与性病学会,中华医学会皮肤性病学分会红斑狼疮研究中心
Formulating unit: Asian Dermatological Association (ADA), Asian Academy of Dermatology and Venereology (AADV), Lupus Erythematosus Research Center of Chinese Society of Dermatology (CSD)
注册时间: 2021-07-09
Registration time:
注册编号: IPGRP-2021CN189
Registration number:
指南制订的目的: 皮肤红斑狼疮(CLE)可分为多种亚型,临床特征各不相同。对CLE患者的治疗需要综合考虑疾病严重程度、治疗反应和潜在的药物不良反应等因素,制定个体化治疗方案。本指南旨在为皮肤科医师、风湿科医师诊治CLE患者提供实用性帮助和参考。指南的各项推荐内容主要基于临床证据和(或)专家共识。
Purpose of the guideline: Cutaneous lupus erythematosus (CLE) can be divided into various subtypes, each with its distinct clinical characteristics. The treatment for patients with CLE needs to be adjusted individually, taking into account both the severity of disease, treatment response and potential side effects. The purpose of this guideline is to help dermatologists and rheumatologists better care for patients with CLE. The recommendations will be based on both evidence and experts’ consensus.